Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Biotage Report Publication Announcement 2011

Apr 6, 2011

2894_rns_2011-04-06_ffd53cfa-cd18-4b8c-91bf-bc2547d60e2d.pdf

Report Publication Announcement

Open in viewer

Opens in your device viewer

- -

  • !"-?#- \$\$% &'()) &')'()'# - *+ -?,* ?*

  • /)

- -

0 -1?-\$ 2'/#(34('#35*

0 - ?-65 -\$ /#34)#5 \$ - 2 2- 765 2 - 0 1- 2'#/34#5*

  • 2 - 0-65 2)#'4)#5* 65 7\$ ?.- \$ . 2? \$. . 0'''#3

0 2 - - 8 ...* ?* -

The information in this press release is of the kind that Biotage AB (publ) may be required to make public according to the Securities Market Act and/or Financial Instruments Trading Act. The information was released for publication at 8.30 am on April 6, 2011.

About Biotage:

Biotage offers solutions, knowledge and experience in the areas of analytical chemistry and medicinal chemistry. The customers include the world's largest pharmaceutical and biotech companies, and leading academic institutes. The company is headquartered in Uppsala and has subsidiaries in the US, UK and Japan. Biotage has 272 employees and had sales of 428.9 MSEK in 2010. Biotage is listed on the NASDAQ OMX Nordic Stockholm stock exchange. Website:www.biotage.com

  • ...* ?* -